FAB — Fusion Antibodies Share News
0.000.00%
Last trade - 00:00- £7.57m
- £6.86m
- £2.11m
Brief: Fusion Antibodies Says National Cancer Institute Proposes Extension Of Collaboration Agreement
RCS - Fusion Antibodies - Mammalian Display video
Fusion Antibodies - Holding(s) in Company
Brief: Fusion Antibodies H1 Pretax Profit GBP -548 Thousand
Fusion Antibodies - Half-year Financial Report
Fusion Antibodies - Notice of Results
RCS - Fusion Antibodies - OptiMAL Library video
Brief: Fusion Antibodies Says On Track For Commercial Launch Of Optimal In December 2025
Fusion Antibodies - OptiMAL® R&D Update
Fusion Antibodies - Holding(s) in Company
Fusion Antibodies - AGM statement and H1 trading update
Fusion Antibodies - Contract win
Fusion Antibodies - Posting of Annual Report & Notice of AGM
Fusion Antibodies - OptiMAL R&D Update
RCS - Fusion Antibodies - Belfast investor presentation
Fusion Antibodies - Final Results
Fusion Antibodies - Contract Win
Brief: Fusion Antibodies Announces Contract Wins With Existing Client
Fusion Antibodies - Contract wins with existing client